An electronic prescription for glipizide 10mg is received by a pharmacist for a new patient. What form of assessment is the pharmacist utilizing?

The assessment being utilized by the pharmacist, in this case, is diagnosis-based screening. When a pharmacist reviews a new prescription for glipizide, they are likely considering the diagnosis of the patient, which is typically related to type 2 diabetes. The electronic prescription provides important information about the patient's medication needs based on this diagnosis.

Diagnosis-based screening involves evaluating a patient's medications in the context of their health conditions, particularly when initiating therapy for a specific diagnosis. This enables the pharmacist to determine whether the prescribed medication is appropriate based on the patient's known medical history or diagnosis. It ensures that the treatment aligns with evidence-based practices for managing conditions like diabetes.

In this scenario, the focus on the patient's need for glipizide, a medication used for controlling blood sugar levels, highlights the direct correlation between the diagnosis of diabetes and the medication being prescribed, reinforcing the use of diagnosis-based screening as the correct form of assessment.